PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy. mmaiocro@gmail.com.\', \'NIBIT Foundation Onlus, Genova, Italy.\', \'The Angeles Clinic and Research Institute, Los Angeles, California.\', \'The Royal Marsden Hospital, London, United Kingdom.\', \'Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.\', \'Toscana Life Sciences Foundation, Siena, Italy.\', \'Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.\', \'Department of Medicine, Gustave Roussy and Paris-Saclay University, Villejuif, France.\', \'Parker Institute For Cancer Immunotherapy, San Francisco, California.\', \'Human Tumor Immunobiology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1158/1078-0432.CCR-20-1657
?:doi
?:hasPublicationType
?:journal
  • Clinical cancer research : an official journal of the American Association for Cancer Research
is ?:pmid of
?:pmid
?:pmid
  • 32540850
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32540850>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32540850>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all